The monopolar VIVA II and its predecessor VIVA RF Electrode are the very first electrodes on the market featuring an adjustable active tip length to achieve a sustained volume reduction in large vascular nodules with the use of a single electrode.
It offers a wide range of sizes to target multiple body systems with precise and reliable performance.
Most cases of tumor regrowth occur as a result of insufficiently ablated tumor margins. The adjustability of VIVA II enables higher energy delivery with the bigger tip in the central portion of the tumors as well as lower energy, precision-controlled smaller ablations around the periphery, completing the RFA procedure with a single electrode.
The active tip can easily be adjusted by sliding the button on the handle, from 5 to 30 mm, in 5 mm increments.
With enhanced visibility of the level markings, tip length adjustment is made easy for you during the procedure.
The VIVA II handle is light and small for better precision-control along with comfortable grip to enable a safe and efficient treatment process.
Scalpel-sharp trocar tip features smooth tissue puncturability without the need of an incision
Convenient tubing system design is added to the VIVA II with Clear-up clips to simplify tubing organization and procedure management.
Disclosures & Important Safety Information
Patients should talk to their doctor to decide if any TaeWoong Medical USA procedure is right for them. Patients and doctors should review all available information on non-surgical and surgical options and associated risks in order to make an informed decision.
Serious complications may occur in any surgery, including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use.
Individuals’ outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.
